MeSH term
Frequency | Condition_Probility | Cell Line | 4 | 0.0 |
Humans | 18 | 0.0 |
Protein Binding | 4 | 0.0 |
Protein Structure, Tertiary | 3 | 0.0 |
Recombinant Fusion Proteins/metabolism | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 16 | 0.0 |
Trans-Activation (Genetics) | 2 | 0.0 |
Transcription Factors/chemistry/*metabolism | 2 | 1.0 |
Two-Hybrid System Techniques | 2 | 0.0 |
Animals | 11 | 0.0 |
DNA-Binding Proteins/genetics | 3 | 0.0 |
Female | 6 | 0.0 |
Gene Expression Regulation, Developmental | 3 | 0.0 |
Homeodomain Proteins/*genetics | 5 | 1.0 |
In Situ Hybridization | 2 | 0.0 |
Mice | 9 | 0.0 |
Pregnancy | 2 | 0.0 |
Transcription Factors/*genetics | 5 | 0.0 |
Tumor Cells, Cultured | 7 | 0.0 |
Amino Acid Sequence | 10 | 0.0 |
Cloning, Molecular | 4 | 0.0 |
Nuclear Proteins/chemistry | 2 | 7.0 |
Zinc/chemistry | 2 | 6.0 |
Comparative Study | 4 | 0.0 |
Mice, Inbred C57BL | 2 | 0.0 |
Molecular Sequence Data | 10 | 0.0 |
*Oncogene Proteins | 2 | 3.0 |
Research Support, U.S. Gov't, P.H.S. | 7 | 0.0 |
Sequence Alignment | 4 | 0.0 |
Base Sequence | 6 | 0.0 |
Male | 3 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 4 | 0.0 |
Cell Differentiation | 2 | 0.0 |
Sequence Homology, Amino Acid | 5 | 0.0 |
*Embryonic and Fetal Development | 2 | 1.0 |
Homeodomain Proteins/*chemistry | 2 | 14.0 |
Immunohistochemistry | 2 | 0.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Transcription Factors/*chemistry | 2 | 4.0 |
Circular Dichroism | 2 | 0.0 |
DNA-Binding Proteins/*metabolism | 2 | 0.0 |
Models, Molecular | 2 | 0.0 |
*Mutation | 2 | 0.0 |
DNA-Binding Proteins/metabolism | 2 | 0.0 |
Homeodomain Proteins/*metabolism | 2 | 1.0 |
Polymerase Chain Reaction | 2 | 0.0 |
*Gene Expression Regulation | 2 | 0.0 |
Protein Conformation | 3 | 0.0 |
